1,322 results on '"Dalakas, Marinos C."'
Search Results
2. List Of Contributors
3. Autoimmune inflammatory myopathies
4. Autoimmune Peripheral Neuropathies
5. The Spectrum of Inflammatory Myopathies: Dermatomyositis, Polymyositis, Necrotizing Myositis, Anti-synthetase Syndrome-overlap Myositis, and Inclusion-Body Myositis
6. Post-COVID Small Fiber Neuropathy, Implications of Innate Immunity, and Challenges on IVIG Therapy
7. Autoimmune Neurogenic Dysphagia
8. Advances in the therapeutic algorithm for myasthenia gravis
9. Therapeutic Antibodies in Neurological Diseases: Witnessing the Continuation of the Impressive Success in Neuro-Immunotherapies
10. The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies
11. Autoimmune Neurological Disorders with IgG4 Antibodies: a Distinct Disease Spectrum with Unique IgG4 Functions Responding to Anti-B Cell Therapies
12. Evolution of Anti-B Cell Therapeutics in Autoimmune Neurological Diseases
13. Stiff-person Syndrome and GAD Antibody-spectrum Disorders: GABAergic Neuronal Excitability, Immunopathogenesis and Update on Antibody Therapies
14. Progressive multifocal fibrosing neuropathy: description of a novel disease
15. Stiff Person Syndrome and GAD Antibody--Spectrum Disorders.
16. Severe Stiff-Person Syndrome After COVID
17. Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
18. N2 Year in Review
19. Treatment and Management of Autoimmune Myopathies
20. Contributors
21. Severe Stiff-Person Syndrome After COVID: The First Video-Documented COVID Exacerbation and Viral Implications
22. Comment: Humoral and T-cell Immunities to SARS-CoV-2 Vaccines: Safety, Efficacy, and Challenges in Autoimmune Neurology
23. Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID
24. Complement in neurological disorders and emerging complement-targeted therapeutics
25. Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
26. Treatment for inclusion body myositis
27. Use of Intravenous Immunoglobulin in Neurology
28. Treatment of Stiff-Person Syndrome
29. IgG4-Mediated Neurologic Autoimmunities: Understanding the Pathogenicity of IgG4, Ineffectiveness of IVIg, and Long-Lasting Benefits of Anti–B Cell Therapies
30. Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
31. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity
32. Immunotherapy in myasthenia gravis in the era of biologics
33. LGI1 encephalitis with squamous lung-cell carcinoma: Resolution after tumor resection
34. N2 year in review
35. Spatial and Ecological Factors Modulate the Incidence of Anti-NMDAR Encephalitis—A Systematic Review
36. Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria
37. Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients
38. The Spectrum of Inflammatory Myopathies: Dermatomyositis, Polymyositis, Necrotizing Myositis, and Inclusion-Body Myositis
39. Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder
40. Late-onset stiff-person syndrome: challenges in diagnosis and management.
41. Immunopathogenesis of Inflammatory Myopathies
42. Autoimmune Peripheral Neuropathies
43. List of Contributors
44. Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies
45. N2 year in review
46. Trial of canakinumab, an IL-1β receptor antagonist, in patients with inclusion body myositis
47. Therapies in Stiff-Person Syndrome
48. MiRP2 Forms Potassium Channels in Skeletal Muscle with Kv3.4 and Is Associated with Periodic Paralysis
49. Objectivity, Practicality, and Significance of Practice Guidelines for the Practicing Neurologists: What We Learnt From Consensus Criteria in CIDP, Myasthenia Gravis and Inflammatory Myopathies
50. Myositis, Pathogenesis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.